Document is current
Any future updates will be listed below
-
Authors
Fuchs, Philipp
Schmidt-Erfurth, Ursula
Coulibaly, Leonard M.
Bogunovic, Hrvoje
Leingang, Oliver
Gruber, Anastasiia
Frommlet, Florian
Mares, Virginia
Barthelmes, Daniel
Reiter, Gregor S.
- License Information
-
More Information
Article History
Received: 27 January 2025
Accepted: 25 August 2025
First Online: 25 September 2025
Declarations
:
: GSR: Grant from RetInSight. US-E: Scientific consultancy for Apellis, Novartis, Roche, Heidelberg Engineering, Kodiak, RetInSight, Topcon. DB: Scientific consultancy, grants and speaker fees for Bayer and Novartis. HB: Grants from Heidelberg Engineering and Apellis. Speaker fees from Bayer, Roche, and Apellis. VM, OL, PF, LC, FF, AG: No financial support or conflicts of interest. The other authors declare no competing interests.
: The study was conducted in adherence with the principles of the Declaration of Helsinki and was approved by the Institutional Review Board (Cantonal Ethics Committee Zurich, Switzerland) for data use and by the Medical University of Vienna (Vienna, Austria) Ethics Committee for the post hoc analysis. Due to the retrospective nature of the study, the need to obtain informed consent was waived by the Cantonal Ethics Committee Zurich, Switzerland, for data use, and by the Ethics Committee of the Medical University of Vienna, Austria, for the post hoc analysis.
